The experimental results suggested that Lv-PD1-γδ T cells could attenuate or eliminate immunosuppression and maximize cytotoxicity by secreting anti-PD1 antibodies locally in the tumor and thus could serve as a promising anticancer “off-the-shelf” cell therapy (176). This evidence concerns the gene PDCD1 and neoplasm.